Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioadaptives Inc (OP: BDPT )

0.0004 -0.0001 (-20.00%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 68,029,944
Open 0.0004
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0005
Today's Range 0.0003 - 0.0005
52wk Range 0.0003 - 0.0083
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioAdaptives, Inc. Announces Intention to Spin off Its Livestock Impact Division as a Wholly-owned Subsidiary With Further Expansion in Botanical Drug Development and Animal Health Markets
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Bioavailable Resveratrol for Both Animals and Humans
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-42.86%
-42.86%
1 Month
-33.33%
-33.33%
3 Month
-42.86%
-42.86%
6 Month
-63.64%
-63.64%
1 Year
-91.84%
-91.84%

More News

Read More
BioAdaptives Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Visionary Futurist, Wellness Pioneer and Marketer, David Allen, PhD
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
BioAdaptives, Inc. (OTC BDPT) Announces the Appointment of Flying C Bar Ranch Therapy Division as Its Exclusive Marketing Agent for Its LiveStock Impact Line of Performance Equine and Pet Supplements
Via NewMediaWire
BioAdaptives Announces Signing of Non-Exclusive Marketing Agreement With World Wellness, LLC for the Launching of Weight Management System Including an AI Supported Body Composition Measuring App and New Health Products
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives, Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Internationally Acclaimed Health Scientist, Author and Patent Holder, Dr. Yaguang Liu
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
BioAdaptives Inc. Announced Today the Signing of a License for Eye Health Due to Myopia and Presbyopia; a Patent Valued at US$ 570,000,000
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Product for Glucose Management
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
Bioadaptives (OTC Pink: BDPT) Signs LOI with World Wellness, LLC to Develop New Health and Wellness Products
Via Spotlight Growth
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
BioAdaptives Announces Signing of Letter of Intent With World Wellness, LLC for the Launching of Weight Management System Including an AI Supported Body Composition Measuring App and New Health Products
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioAdaptives, Inc. Establishes a Wholesale Division to Expand Marketing Presence in a USD 151.9 Billion Global Dietary Supplement Market
Via NewMediaWire
BioAdaptives, Inc. Introduces PROTEINnMORE, an Advanced, Plant-Based Lean Muscle Supplement for Fitness and Athletic Peak Performance
Via NewMediaWire
As Global Anti-aging Product Annual Sales are Expected to Exceed 44 Billion by 2027, BioAdaptives, Inc. Launches Cell Rejuven, an Advanced, Plant-Based Anti-Aging Supplement With Rejuvenating Effects
Via NewMediaWire
Topics Derivatives
Exposures Derivatives
BioAdaptives Launches MindnMemory Nootropic Mental Focus, Clarity, Concentration
Via NewMediaWire
BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners
Via NewMediaWire
Exposures COVID-19
BioAdaptives, Inc. Introduces PrimiSleep, An Advanced Sleep-Aid Designed to Harmonize with the Body's Unique Circadian Rhythm, Delivering Gentle, Sustained, Restorative Sleep With No "Hangover"
Via NewMediaWire
BioAdaptives, Inc. Brings Top Revolutionary Formulas Together in Wellness Introductory Offer
Via NewMediaWire
Exposures COVID-19
BioAdaptives, Inc. Seeks to Increase Market Share in $1.9 Billion Global Pet Supplements Market With Canine All-In-One Premium Nutraceutical
Via NewMediaWire
Topics Derivatives
Exposures Derivatives
BioAdaptives, Inc. Reveals Corporate Strategy for a Strengthened Market Presence, Through Empowerment of Seniors, as Nutraceutical Market Surpasses $454 Billion USD
Via NewMediaWire
BioAdaptives Sponsors COVID-19 Long Hauler Survey
Via NewMediaWire
Exposures COVID-19
BioAdaptives Expands Gadolinium Deposition Disease Survey
Via NewMediaWire
BioAdaptives Announces Initial Investigation Results Pluripain Improves Symptoms of Gadolinium Deposition Disease
Via NewMediaWire
BioAdaptives Acquires Oxygenated Water Technology Patent and Forms Subsidiary, MORO2, Inc., to Create New Products
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
BioAdaptives to Investigate Use of Lung Cleanser for Long-Term Smokers
Via NewMediaWire
BioAdaptives Signs Letter of Intent to Acquire Oxygenated Water Technology Patent
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.